Published in Pacing Clin Electrophysiol on November 01, 2008
Stratification of the risk of sudden death in nonischemic heart failure. Arq Bras Cardiol (2014) 0.78
Variations of QRS Morphology in Patients with Dilated Cardiomyopathy; Clinical and Prognostic Implications. J Cardiovasc Thorac Res (2014) 0.75
Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA (2002) 4.48
Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology (2003) 3.41
Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol (2007) 3.09
Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation (2007) 2.36
Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med (2008) 2.17
Indications for the use of diagnostic implantable and external ECG loop recorders. Europace (2009) 2.06
Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol (2012) 2.02
Electroanatomic characterization of post-infarct scars comparison with 3-dimensional myocardial scar reconstruction based on magnetic resonance imaging. J Am Coll Cardiol (2008) 2.00
Mechanisms of right atrial tachycardia occurring late after surgical closure of atrial septal defects. J Cardiovasc Electrophysiol (2005) 1.98
Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis (2012) 1.97
Cryoablation versus radiofrequency energy for the ablation of atrioventricular nodal reentrant tachycardia (the CYRANO Study): results from a large multicenter prospective randomized trial. Circulation (2010) 1.91
A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J (2012) 1.91
Ethics and observational studies in medical research: various rules in a common framework. Int J Epidemiol (2009) 1.85
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J (2006) 1.84
Does insulin glargine increase the risk of cancer compared with other basal insulins?: A French nationwide cohort study based on national administrative databases. Diabetes Care (2012) 1.76
Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. J Am Coll Cardiol (2008) 1.66
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J (2008) 1.64
Methyl donor deficiency induces cardiomyopathy through altered methylation/acetylation of PGC-1α by PRMT1 and SIRT1. J Pathol (2011) 1.61
Prospective assessment of short- and long-term quality of life after ablation for atrial fibrillation. J Cardiovasc Electrophysiol (2011) 1.52
A new dual-chamber pacing mode to minimize ventricular pacing. Pacing Clin Electrophysiol (2005) 1.52
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Prognostic value of skin manifestations of infective endocarditis. JAMA Dermatol (2014) 1.51
Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol (2011) 1.51
Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine. Anesthesiology (2010) 1.50
Rapid and low-cost method to prove the nature of no documented tachycardia in children and teenagers without pre-excitation syndrome. Europace (2009) 1.48
Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail (2006) 1.45
Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy. Eur Heart J (2008) 1.44
Dissociated pulmonary vein activity after pulmonary vein isolation for paroxysmal atrial fibrillation: a predictor for recurrence? J Cardiovasc Electrophysiol (2014) 1.44
Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality. Eur Heart J (2006) 1.43
Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol (2005) 1.43
Isthmus characteristics of reentrant ventricular tachycardia after myocardial infarction. Circulation (2002) 1.27
Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J (2003) 1.21
Automatic home monitoring of implantable cardioverter defibrillators. Europace (2008) 1.21
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace (2013) 1.16
Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study. Eur J Heart Fail (2002) 1.14
The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J (2009) 1.14
Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Med (2010) 1.11
Sudden death in noncoronary heart disease is associated with delayed paced ventricular activation. Circulation (2003) 1.09
Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study. Circulation (2005) 1.06
Electroanatomic mapping characteristics of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Europace (2005) 1.06
Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction. Europace (2007) 1.05
Detection of myocarditis by contrast-enhanced MRI in patients presenting with acute coronary syndrome but no coronary stenosis. J Magn Reson Imaging (2007) 1.02
Venice Chart International Consensus document on ventricular tachycardia/ventricular fibrillation ablation. J Cardiovasc Electrophysiol (2010) 1.00
International consensus on nomenclature and classification of atrial fibrillation: A collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol (2003) 0.98
Cardiac device-related endocarditis caused by Paenibacillus glucanolyticus. J Clin Microbiol (2013) 0.97
Heart failure burden and therapy. Europace (2009) 0.97
In-hospital mortality of infective endocarditis: prognostic factors and evolution over an 8-year period. Scand J Infect Dis (2007) 0.96
Localizing the critical isthmus of postinfarct ventricular tachycardia: the value of pace-mapping during sinus rhythm. Heart Rhythm (2014) 0.96
Myocardial infarction in a 45-year-old man following an anaphylactic reaction to a wasp sting. Int J Cardiol (2009) 0.95
Femoral pseudoaneurysms and current cardiac catheterization: evaluation of risk factors and treatment. Int J Cardiol (2008) 0.95
Aortocaval fistula: an uncommon cause of paradoxical embolism. J Cardiovasc Med (Hagerstown) (2012) 0.94
Diagnostic performance of a dual-chamber cardioverter defibrillator programmed with nominal settings: a European prospective study. J Cardiovasc Electrophysiol (2002) 0.94
Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing. J Am Coll Cardiol (2004) 0.92
A tool to analyze the transferability of health promotion interventions. BMC Public Health (2013) 0.91
Safety and efficacy of a dual chamber implantable cardioverter defibrillator capable of slow ventricular tachycardia discrimination: a randomized study. Pacing Clin Electrophysiol (2003) 0.91
Upgrading from single chamber right ventricular to biventricular pacing in permanently paced patients with worsening heart failure: The RD-CHF Study. Pacing Clin Electrophysiol (2007) 0.91
Transferability of interventions in health education: a review. BMC Public Health (2012) 0.90
Significance of inducible ventricular flutter-fibrillation after myocardial infarction. Pacing Clin Electrophysiol (2005) 0.89
Addition of a second LV pacing site in CRT nonresponders rationale and design of the multicenter randomized V(3) trial. J Card Fail (2010) 0.89
Cardiac impact of the arteriovenous fistula after kidney transplantation: a case-controlled, match-paired study. Transpl Int (2008) 0.89
Clinical and microbiologic features of multivalvular endocarditis. Curr Infect Dis Rep (2010) 0.89
Paradoxical effect of isoprenaline infusion. Europace (2005) 0.89
Left bundle branch block and mortality in patients with acute heart failure syndrome: a substudy of the EFICA cohort. Eur J Heart Fail (2009) 0.89
Complete atrioventricular block during ablation of atrial flutter. Pacing Clin Electrophysiol (2009) 0.88
Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin Infect Dis (2004) 0.88
Teaching ethics in Europe. J Med Ethics (2007) 0.88
Impact of local agricultural and industrial practices on organic contamination of little egret (Egretta garzetta) eggs in the Rhone Delta, southern France. Environ Toxicol Chem (2002) 0.87
Non-invasive investigations of the right heart: how and why? Arch Cardiovasc Dis (2009) 0.87
Rationale and current perspective for early rhythm control therapy in atrial fibrillation. Europace (2011) 0.87
Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: a substudy of the ECOST trial. J Cardiovasc Electrophysiol (2014) 0.86
Aortic valve replacement for active infective endocarditis: 5-year survival comparison of bioprostheses, homografts and mechanical prostheses. Eur J Cardiothorac Surg (2009) 0.86